In Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Metabolic Conditions are Independently Associated with Mortality

被引:0
|
作者
Younossi, Zobair M. [1 ,3 ]
Otgonsuren, Munkhzul [3 ]
Locklear, Cameron T. [2 ]
Venkatesan, Chapy [2 ]
Mishra, Alita [2 ]
Erario, Madeline [2 ]
Srishord, Manirath [3 ]
Racila, Andrei [3 ]
Arsalla, Aimal [3 ]
Kalwaney, Shirley K. [2 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Inova Hlth Syst, Dept Med, Falls Church, VA USA
[3] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
575
引用
收藏
页码:495A / 495A
页数:1
相关论文
共 50 条
  • [41] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [42] Serum Biomarkers Associated with Coronary Artery Disease in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Elsheikh, Elzafir
    Tran, Henry A.
    Paik, James
    Felix, Sean C.
    Jeffers, Thomas
    Younoszai, Zahra
    Allawi, Hussain
    Racila, Andrei
    Lam, Brian P.
    Schneider, Ingrid
    Gerber, Lynn
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 625A - 626A
  • [43] Metabolic study in patients with non-alcoholic fatty liver disease
    Benhaim Varela, Marcela Estela
    Leonardo Guma, Carlos
    Doglia Garca, Liliana Iris
    Guadalupe Canella, Viviana
    Lopez Gargiulo, Susana Veronica
    Pengue Naccarella, Claudia
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (01): : 11 - 16
  • [44] The Increase in Mortality Related to Chronic Liver Disease Is Explained By Non-Alcoholic Fatty Liver Disease (NAFLD)
    Paik, James
    Golabi, Pegah
    Sayiner, Mehmet
    Biswas, Rakesh
    Alqahtani, Saleh
    Venkatesan, Chapy
    Younossi, Zobair M.
    HEPATOLOGY, 2018, 68 : 453A - 453A
  • [45] In Female Patients with Non-alcoholic Fatty Liver Disease (NAFLD), Presence of Type 2 Diabetes (DM) and Chronic Kidney Disease (CKD) are Independently Associated with the Risk of Mortality
    Stepanova, Maria
    de Avila, Leyla
    Birerdinc, Aybike
    Noor, Bashir
    Badoe, Nina
    Younossi, Zobair M.
    HEPATOLOGY, 2015, 62 : 1282A - 1283A
  • [46] Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease:Is this plausible?
    Jalpa Devi
    Aimun Raees
    Amna Subhan Butt
    World Journal of Hepatology, 2022, 14 (01) : 158 - 167
  • [47] Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
    Devi, Jalpa
    Raees, Aimun
    Butt, Amna Subhan
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (01) : 158 - 167
  • [48] Non-Alcoholic Fatty Liver Disease Fibrosis Score (NFS) is an Independent Predictor of Mortality in Patients with NAFLD
    Younossi, Zobair M.
    Stepanova, Maria
    Henry, Linda
    Cooper, James J.
    Kalwaney, Shirley K.
    Venkatesan, Chapy
    Mishra, Alita
    HEPATOLOGY, 2013, 58 : 511A - 511A
  • [49] ARE THERE DIFFERENT PREDICTORS OF MORTALITY IN LEAN AND OBESE/OVERWEIGHT PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)?
    Golabi, Pegah
    Otgonsuren, Munkhzul
    Tan, Daisong
    de Avila, Leyla
    Locklear, Cameron T.
    Fukui, Natsu
    Arsalla, Aimal
    Gogoll, Trevor
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2017, 152 (05) : S684 - S684
  • [50] Beyond the liver in patients with non-alcoholic fatty liver disease (NAFLD)-cause for concern?
    Armstrong, Matthew J.
    Haydon, Geoffrey
    Syn, Wing-Kin
    HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (02) : 138 - 142